BRITTNEY SIDES: Open Payments
NPI 1255920203 · DECATUR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 21 payments from 11 companies in 2025. Trend: 2023 $603 · 2024 $316 · 2025 $406
Food & beverage: $406
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $104 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| Novo Nordisk Inc | 2 | $38 |
| MERZ NORTH AMERICA, INC. | 1 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| ABBVIE INC. | 2 | $34 |
| Antares Pharma, Inc. | 1 | $27 |
| Indivior Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $15 |
Products named: CAPLYTA, AIRSUPRA, FARXIGA, Kerendia, XYOSTED, SUBLOCADE, REXULTI, Rybelsus.
Industry payments across AL — which companies pay providers there.
